Check-Cap (NASDAQ:CHEK) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Check-Cap (NASDAQ:CHEK) in a research report report published on Saturday morning. The brokerage issued a sell rating on the medical research company’s stock.

Check-Cap Price Performance

Shares of NASDAQ CHEK traded down $0.08 during mid-day trading on Friday, hitting $1.00. The company’s stock had a trading volume of 46,223 shares, compared to its average volume of 16,083. The stock has a market cap of $5.85 million, a price-to-earnings ratio of -0.33 and a beta of 0.39. Check-Cap has a one year low of $1.00 and a one year high of $3.85. The company’s fifty day simple moving average is $1.47 and its 200-day simple moving average is $1.87.

Check-Cap Company Profile

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation.